glp-1 drugs and thyroid cancer GLP-1RA cancer: New study suggests detection bias, not causation Increased GLP-1 Thyroid Cancer Risks
Description
The most frequently reported adverse effects of GLP-1 receptor agonists are gastrointestinal in nature
After six months, both the treatment group and placebo group (who did not receive the supplement) saw significant improvements in their BMI
But don't just take our word for it
Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ
Phase 3 trial of semaglutide in metabolic dysfunctionassociated steatohepatitis
Is Mounjaro a better option for patients with obesity but no diabetes
